Catalyst Wire Dossier Catalyst Wire Dossier

Risedronate and cholecalciferol combination tablet

· Hanlim Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Risedronate and cholecalciferol combination tablet, covering 2019-08-05 to 2019-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis [Phase 4]

See pricing